IVIG对乳腺癌细胞株MDA-MB-453体外增殖抑制作用的实验研究

IVIG对乳腺癌细胞株MDA-MB-453体外增殖抑制作用的实验研究

详细信息

中图分类号: R737.9
计量
- 文章访问数: 177
- HTML全文浏览量: 32
- PDF下载量: 0
出版历程
- 发布日期: 2009-11-29

摘要

摘要: 静脉注射丙种球蛋白(IVIG), 来源于健康志愿者捐献的血浆经灭菌、分离得到,因此是一种源自人体的安全的生物制品.IVIg主要适用于血小板减少性紫癜(ITP)、自体免疫疾病以及免疫介导的疾病的治疗[1-2].近年来,有文献报道IVIG还可用于治疗各种肿瘤,有一定的临床效果[3-4].乳腺癌是严重威胁人类健康的常见病和多发病,乳腺癌新发病人数每年有增加的趋势.本实验是利用目前较为先进的ATP-荧光发光法检测抑瘤率并结合流式细胞仪检测肿瘤细胞周期、凋亡指数,来探索IVIG体外对乳腺癌细胞增殖的影响.
- IVIG(静脉注射丙种球蛋白) /
- MDA-MB-453 /
- 乳腺癌

HTML全文

参考文献(8)

Ephrem A, Misra N, Hassan G. ImmunomoduLation of autoimmune and inf Lammatory diseases with intravenous immunogLobuLin [J]. Clinical and Experimental Medicine, 2005(4):135.

ShoenfeLd Y, Krause I I v. IG for autoimmune, fibrosis, and maLignant conditions:our experience with 200 patients [J]. Journal of Clinical Immunology, 2004(2):107.doi: 10.1023/B:JOCI.0000019809.55787.ec.

SheLton B K, Griffin J M, GoLdman F D. Immune gLobuLin IV therapy:optimizing care of patients in the oncoLogy setting [J]. Oncology Nursing Forum, 2006(5):911.doi: 10.1188/06.ONF.911-921.

Damianovich M, SoLomon A S, BLank M. Attenuation of coLon carcinoma tumor spread by intravenous immunogLobuLin [J]. Annals of the New York Academy of Sciences, 2007.567.doi: 10.1196/annals.1423.061.

Renfro W H, Paryani S G. Criteria for use of intravenous immune gLobuLin (IVIG) [J]. Clinical Pharmacy, 1990(7):550.

Fishman P, Bar-Yehuda S, ShoenfeLd Y. IVIg to prevent tumor metastases (Review) [J]. International Journal of Oncology, 2002(4):875.

Webb S J, Harrison D J, WyLLie A H. Apoptosis:an overview of the process and its reLevance in disease [J]. Advances in Pharmacology, 1997.1.doi: 10.1016/S1054-3589(08)61052-2.

Prasad N K, Papoff G, Zeuner A. Therapeutic preparations of normaL poLyspecific IgG (IVIg) induce apoptosis in human Lymphocytes and monocytes:a noveL mechanism of action of IVIg invoLving the Fas apoptotic pathway [J]. Journal of Immunology, 1998(7):3781.